Gene · 9221
Papers1,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A membrane-penetrating modified ascites-derived peptide, TAT-CPAP1, sensitizes TP53 wild-type ovarian cancer cells to platinum-based therapy through targeting the NOLC1-MDM2/MDM4 axis. | Transl Oncol | 2026 | 42822321 | PubTator, text mining | PubMed |
| The p53-Associated Regulation of ATF4 mRNA Expression Involves p21 and p130 in a Stress-Dependent Manner. | Cells | 2026 | 42782813 | PubTator, text mining | PubMed |
| Nuclear-targeted GDOWN1 potently suppresses tumors by inducing premature transcription termination and exporting Pol Ⅱ CTD phosphatases to activate RB. | Cell Death Differ | 2026 | 42649379 | PubTator, text mining | PubMed |
| Nucleolar and coiled-body phosphoprotein 1 enhances the induction of CYP3A4 by promoting nuclear translocation of pregnane X receptor. | Drug Metab Dispos | 2026 | 42526206 | PubTator, text mining | PubMed |
| Preferential Upregulation of AMOT-p80 Is Associated with YAP-Linked Resistance to 5-Fluorouracil and Oxaliplatin in Colorectal Cancer Cells. | Biomolecules | 2026 | 42352235 | PubTator, text mining | PubMed |
| CircNOLC1/KRT16 promotes colorectal cancer invasion and migration via c-met nuclear translocation and reprogramming of the oxidative pentose phosphate pathway. | J Biol Chem | 2026 | 41861993 | PubTator, text mining | PubMed |
| Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade. | Proc Natl Acad Sci U S A | 2026 | 41860961 | PubTator, text mining | PubMed |
| Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments. | Int J Mol Sci | 2026 | 41751791 | PubTator, text mining | PubMed |
| Beyond Ion Channels: Emerging Roles of FGF12 in Cellular Regulation and Cancer Progression. | Cells | 2026 | 41744813 | PubTator, text mining | PubMed |
| PFKP binding AMOTL1 promotes tumor aerobic glycolysis and epithelial-mesenchymal transition by modulating Hippo pathway in head and neck cancer. | J Transl Int Med | 2026 | 41727965 | PubTator, text mining | PubMed |
| Nucleolar targeting of lyssavirus P-protein is isoform- and phylogroup-specific. | J Gen Virol | 2026 | 41543529 | PubTator, text mining | PubMed |
| Directed evolution on compact landing pads yields highly efficient recombinases for large DNA integration. | Nucleic Acids Res | 2026 | 41495889 | PubTator, text mining | PubMed |
| Programmable large-cargo integration: Overcoming size constraints for next-generation gene therapy. | Synth Syst Biotechnol | 2026 | 41438771 | PubTator, text mining | PubMed |
| Making order from disorder in the nucleolus. | Genes Dev | 2026 | 41381365 | PubTator, text mining | PubMed |
| Intrinsically disordered regions stimulate concentration of small nucleolar ribonucleoproteins and formation of Cajal bodies and nucleoli. | Genes Dev | 2026 | 41298079 | PubTator, text mining | PubMed |
| FTO Suppresses Dental Pulp Stem Cell Senescence by Destabilizing NOLC1 mRNA. | Biomolecules | 2025 | 41301545 | PubTator, text mining | PubMed |
| The CoREST Complex Regulates Alternative Splicing by the Transcriptional Regulation of RNA Processing Genes in Melanoma Cells. | Cells | 2025 | 41227344 | PubTator, text mining | PubMed |
| NOLC1 as Key Regulator of NPR1 (Coding for NPRA) Transcription in Endothelial Senescence. | Genesis | 2025 | 41195691 | PubTator, text mining | PubMed |
| Focal Adhesion of Collagen-Based Bone Grafting Materials Enhances Bone Regeneration. | Bioengineering (Basel) | 2025 | 41155014 | PubTator, text mining | PubMed |
| An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. | Nat Commun | 2025 | 40993118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9221/papers